Table 2.
SGA induced urinary retention
Case (n) | No case (n) | Total | % | ROR | 95%CI | |
---|---|---|---|---|---|---|
All | 4653 | 883,051 | 887,704 | 0.52 | ||
Clozapine | 8 | 3605 | 3613 | 0.22 | 0.42 | 0.210–0.841 |
Risperidone | 57 | 4404 | 4461 | 1.28 | 2.47 | 1.902–3.218 |
Paliperidone | 12 | 1721 | 1733 | 0.69 | 1.32 | 0.750–2.338 |
Perospirone | 4 | 589 | 593 | 0.67 | 1.29 | 0.482–3.448 |
Asenapine | 7 | 544 | 551 | 1.27 | 2.44 | 1.159–5.154 |
Olanzapine | 43 | 3185 | 3228 | 1.33 | 2.58 | 1.905–3.486 |
Quetiapine | 52 | 3392 | 3444 | 1.51 | 2.93 | 2.225–3.860 |
Aripiprazole | 43 | 3983 | 4026 | 1.07 | 2.06 | 1.522–2.784 |
Blonanserin | 18 | 1130 | 1148 | 1.57 | 3.03 | 1.901–4.833 |
Brexpiprazole | 12 | 575 | 587 | 2.04 | 3.97 | 2.239–7.034 |
Lurasidone | 21 | 577 | 598 | 3.51 | 6.93 | 4.482–10.727 |
SGA, second-generation antipsychotics; ROR, reporting odds ratio; 95%CI, 95% confidence interval